Literature DB >> 20594556

Acute infection with Epstein-Barr virus is associated with atherogenic lipid changes.

F Apostolou1, I F Gazi, K Lagos, C C Tellis, A D Tselepis, E N Liberopoulos, M Elisaf.   

Abstract

OBJECTIVE: To evaluate the effects of acute infection with Epstein-Barr virus (infectious mononucleosis, IM) on lipids and lipoproteins.
METHODS: Fasting serum levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (TGs), apolipoproteins (apo) A-I, B, E, C-II, C-III and lipoprotein (a) [Lp(a)] were determined in patients with IM on diagnosis and 4 months after the resolution of febrile illness and in age- and sex-matched controls. Activities of cholesteryl-ester transfer protein (CETP), lipoprotein-associated phospholipase A2 (Lp-PLA2) and paraoxonase 1 (PON1) as well as levels of several cytokines were determined. LDL subclass analysis was performed with the Lipoprint LDL System.
RESULTS: Twenty-nine patients (16 males, aged 24.3±14.6 years) and 30 controls were included. TC, HDL-C, LDL-C, apoA-I, apoB, apoC-III and Lp(a) levels were lower at baseline whereas apoB/apoA-I ratio, TG levels and CETP activity were elevated compared with 4 months later. At baseline, higher levels in cytokines and the cholesterol concentration of small-dense LDL particles (sdLDL-C) were noticed, whereas LDL particle size was lower compared with follow-up. Activities of Lp-PLA2 and PON1 were similar at baseline and 4 months later. Four months after the resolution of IM levels of TGs, apoE, apoC-III, Lp(a), sdLDL-C and cytokines as well as LDL particle size, apoB/apoA-I ratio, CETP and Lp-PLA2 activities were similar to controls. PON1 activities both at baseline and 4 months later were lower in patients compared with controls.
CONCLUSIONS: IM is associated with atherogenic changes of lipids and lipoproteins that are partially restored 4 months after its resolution.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20594556     DOI: 10.1016/j.atherosclerosis.2010.06.006

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  10 in total

Review 1.  Lipid testing in infectious diseases: possible role in diagnosis and prognosis.

Authors:  Sebastian Filippas-Ntekouan; Evangelos Liberopoulos; Moses Elisaf
Journal:  Infection       Date:  2017-05-08       Impact factor: 3.553

2.  Leptospirosis is associated with markedly increased triglycerides and small dense low-density lipoprotein and decreased high-density lipoprotein.

Authors:  Irene F Gazi; Fotini A Apostolou; Evangelos N Liberopoulos; Theodosios D Filippatos; Constantinos C Tellis; Moses S Elisaf; Alexandros D Tselepis
Journal:  Lipids       Date:  2011-06-19       Impact factor: 1.880

3.  Evaluation of Lipid Profile Changes in Pediatric Patients with Acute Mononucleosis.

Authors:  Shirin Sayyahfar; Amin Lavasani; Alireza Nateghian; Abdollah Karimi
Journal:  Infect Chemother       Date:  2017-03-13

4.  Lipid metabolism changes in patients with severe COVID-19.

Authors:  Yi Li; Yan Zhang; Rongli Lu; Minhui Dai; Minxue Shen; Jianchu Zhang; Yanhui Cui; Ben Liu; Fengyu Lin; Lingli Chen; Duoduo Han; Yifei Fan; Yanjun Zeng; Wen Li; Sha Li; Xiang Chen; Haitao Li; Pinhua Pan
Journal:  Clin Chim Acta       Date:  2021-02-24       Impact factor: 3.786

5.  Transient hypertriglyceridemia: a common finding during Epstein-Barr virus-induced infectious mononucleosis.

Authors:  Emilio-Manuel Páez-Guillán; Joaquín Campos-Franco; Rosario Alende; Yago Garitaonaindía; Arturo González-Quintela
Journal:  Lipids Health Dis       Date:  2021-12-12       Impact factor: 3.876

Review 6.  Persistence of Lipoproteins and Cholesterol Alterations after Sepsis: Implication for Atherosclerosis Progression.

Authors:  Krzysztof Laudanski
Journal:  Int J Mol Sci       Date:  2021-09-29       Impact factor: 6.208

7.  Association of Lipid Levels With COVID-19 Infection, Disease Severity and Mortality: A Systematic Review and Meta-Analysis.

Authors:  Vignesh Chidambaram; Harinivaas Shanmugavel Geetha; Amudha Kumar; Marie Gilbert Majella; Ranjith Kumar Sivakumar; Dinesh Voruganti; Jawahar L Mehta; Petros C Karakousis
Journal:  Front Cardiovasc Med       Date:  2022-03-24

8.  High-density lipoproteins may play a crucial role in COVID-19.

Authors:  Minu Nain; Apoorv Gupta; Sumit Malhotra; Amit Sharma
Journal:  Virol J       Date:  2022-08-23       Impact factor: 5.913

9.  Is there any relationship between Chlamydophila pneumoniae and coronary atherosclerosis among Iranians?

Authors:  Mohammad Hadi Sadeghian; Seyed Abbas Tabatabaee Yazdi; Hossein Ayatollahi; Mohammad Reza Keramati; Kiarash Ghazvini; Ali Reza Rezai; Nasrin Heidari; Maryam Sheikhi; Gohar Shaghayegh
Journal:  Niger Med J       Date:  2013-01

Review 10.  Multiple Infectious Agents and the Origins of Atherosclerotic Coronary Artery Disease.

Authors:  James S Lawson
Journal:  Front Cardiovasc Med       Date:  2016-09-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.